Electronic screening for mental illness in patients with psoriasis


Journal article


K. Bechman, Joseph F Hayes, Julian Mathewman, Alasdair D. Henderson, Elizabeth I Adesanya, K. Mansfield, Catherine H. Smith, J. Galloway, S. Langan
British Journal of Dermatology, 2023

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
Bechman, K., Hayes, J. F., Mathewman, J., Henderson, A. D., Adesanya, E. I., Mansfield, K., … Langan, S. (2023). Electronic screening for mental illness in patients with psoriasis. British Journal of Dermatology.


Chicago/Turabian   Click to copy
Bechman, K., Joseph F Hayes, Julian Mathewman, Alasdair D. Henderson, Elizabeth I Adesanya, K. Mansfield, Catherine H. Smith, J. Galloway, and S. Langan. “Electronic Screening for Mental Illness in Patients with Psoriasis.” British Journal of Dermatology (2023).


MLA   Click to copy
Bechman, K., et al. “Electronic Screening for Mental Illness in Patients with Psoriasis.” British Journal of Dermatology, 2023.


BibTeX   Click to copy

@article{k2023a,
  title = {Electronic screening for mental illness in patients with psoriasis},
  year = {2023},
  journal = {British Journal of Dermatology},
  author = {Bechman, K. and Hayes, Joseph F and Mathewman, Julian and Henderson, Alasdair D. and Adesanya, Elizabeth I and Mansfield, K. and Smith, Catherine H. and Galloway, J. and Langan, S.}
}

Abstract

In this cross-sectional study from a large UK centre, screening for mental illness in individuals with psoriasis has demonstrated a high burden of depression and anxiety. Overall, 85% of the cohort reported that their psoriasis had affected their quality of life. Quality-of-life scores correlate with depression scores, emphasizing the importance of managing the individual’s mental health alongside their psoriasis to improve overall quality of life.


Share

Tools
Translate to